Corporate Europe Observatory

Exposing the power of corporate lobbying in the EU

Europe inc.

Europe Inc., published in 2000 by Pluto Press (2nd edition in 2003) in association with Corporate Europe Observatory, provides a unique and comprehensive overview of the systematic ways in which transnational corporations – working through lobby groups – have succeeded in influencing a wide range of policies of the EU and other international institutions, such as the OECD, WTO and the United Nations. The authors cover the major players in these anti-democratic practices and analyse the structural and political factors which have enabled transnational corporations to become such a dominant force in politics.

  • Dansk
  • Nederlands
  • English
  • Suomi
  • Français
  • Deutsch
  • Ελληνικά
  • Italiano
  • Bokmål
  • Polski
  • Portuguese
  • Română
  • Slovenščina
  • Español
  • Svenska
 

Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
CEO just responded to the European Ombudsman’s public consultation on transparency in the negotiations over the Transatlantic Trade and Investment Partnership (TTIP), outlining suggestions for ending the secrecy in the EU-US trade talks.
Story

Call for internship

We are looking for an intern to conduct research on specific issues around the influence of corporate lobbying on EU policy-making processes, as well as to provide support for CEO's ongoing campaign work. Meanwhile we offer you an opportunity to strengthen your research skills and improve your knowledge of EU decision-making.
Our correspondence with Pr. Anne Glover, the current Chief Scientific Adviser to the President of the European Commission (CSA), on her role in the European Commission's review of endocrine disrupting chemicals shows how the very existence of her position was used by business-friendly interests to convey key messages to the top of the European Commission's hierarchy, playing a determining role in the massive delay now inflicted to the European Commission's handling of this important public health regulation. We ask that the CSA position is not renewed in the new Juncker Commission.
Will EFSA become more transparent, and to lobbyists or scientists? After its public consultation on its draft transparency policy, the Authority must now choose.
Corporate Europe Observatory (CEO) today criticised the plenary vote of MEPs to approve the Jean-Claude Juncker Commission.
CEO just responded to the European Ombudsman’s public consultation on transparency in the negotiations over the Transatlantic Trade and Investment Partnership (TTIP), outlining suggestions for ending the secrecy in the EU-US trade talks.

Corporate Europe Forum